As part of the buyer's due diligence process, the letter states that OpenAI must grant it "access to any assets, facilities, ...

Elon Musk and a group of investors made a surprise hostile bid for OpenAI’s operating assets earlier this week—offering $97.4 ...

Musk’s consortium, which includes VCs like Joe Lonsdale’s 8VC and SpaceX investor Vy Capital, is offering exactly $97.375 ...

According to a recently filed letter of intent, Musk and a group of investors have proposed a $97.375 billion all-cash deal ...

"The company is not for sale. It's another one of his tactics to try to mess with us," Altman said, referring to Musk.

Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech ...

A day after Elon Musk announced his $97.4 billion bid to purchase the non-profit that oversees OpenAI, the two parties were ...

A consortium of investors led by Elon Musk recently offered $97.4 billion to buy the non-profit that controls OpenAI. Musk’s ...

In 2017, Ali founded Hex Capital, Canada's first crypto-focused fund, raising $10 million to invest in early-stage blockchain and fintech ventures. Through Hex Capital, he has made notable investments ...

Whether or not an official bid has been sent to OpenAI from Musk, one thing remains clear. Sam Altman, CEO of OpenAI, is not interested in the offer. Altman told Reuters that the non-profit that ...

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for the first authorized use of an ...